Optiver Holding
IMNM icon

Optiver Holding’s Immunome IMNM Stock Holding History

Optiver Holding’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Buy
604
+78
+15% +$1.67K ﹤0.01% 1682
2026
Q1 		$11.5K Buy
526
+116
+28% +$2.58K ﹤0.01% 1197
2025
Q4 		$8.81K Sell
410
-144
-26% -$2.53K ﹤0.01% 1175
2025
Q3 		$6.49K Buy
+554
New +$5.51K ﹤0.01% 1551

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Optiver Holding's IMNM Position: Q2 2026 in Review

Optiver Holding increased its Immunome (IMNM) stake by 15% in Q2 2026, buying an estimated $1.67K and bringing the position to 604 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Optiver Holding first reported a position in IMNM in Q3 2025 and has held it in 4 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Optiver Holding held 604 shares of Immunome worth $12.8K as of Q2 2026.
  • Optiver Holding bought 78 Immunome shares in Q2 2026, an estimated $1.67K.
  • Immunome made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1682 holding.
  • Optiver Holding first reported a position in Immunome in Q3 2025 and has held it in 4 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.